C-Kit controls IL-1β-induced effector functions in HMC-cells

European Journal of Pharmacology

Volumn 675, Issue 1-3, 2012, Pages 57-62

  Drube, Sebastian ^a   Schmitz, Frederike ^a   Göpfert, Christiane ^a   Weber, Franziska ^a   Kamradt, Thomas ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

c Kit; Cross activation; IL 1 ; Mast cell

Indexed keywords

IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; INTERLEUKIN 33; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELL LINE; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84855453148     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.11.035     Document Type: Article

References (32)

1. C. Akin, K. Brockow, C. D'Ambrosio, A.S. Kirshenbaum, Y. Ma, B.J. Longley, and D.D. Metcalfe Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit Exp. Hematol. 31 2003 686 692 (Pubitemid 36945381)
2. S. Ali, M. Huber, C. Kollewe, S.C. Bischoff, W. Falk, and M.U. Martin IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells Proc. Natl. Acad. Sci. U. S. A. 104 2007 18660 18665 (Pubitemid 350210753)
3. M.V. Andrade, S. Iwaki, C. Ropert, R.T. Gazzinelli, J.R. Cunha-Melo, and M.A. Beaven Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33 Eur. J. Immunol. 41 2011 760 772
4. W.P. Arend, G. Palmer, and C. Gabay IL-1, IL-18, and IL-33 families of cytokines Immunol. Rev. 223 2008 20 38 (Pubitemid 351986169)
5. F.D. Bohmer, L. Karagyozov, A. Uecker, H. Serve, A. Botzki, S. Mahboobi, and S. Dove A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP site inhibitor STI-571 J. Biol. Chem. 278 2003 5148 5155 (Pubitemid 36801026)
6. E.K. Brint, D. Xu, H. Liu, A. Dunne, A.N. McKenzie, L.A. O'Neill, and F.Y. Liew ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signalling and maintains endotoxin tolerance Nat. Immunol. 5 2004 373 379 (Pubitemid 38500085)
7. A.A. Chackerian, E.R. Oldham, E.E. Murphy, J. Schmitz, S. Pflanz, and R.A. Kastelein IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex J. Immunol. 179 2007 2551 2555
8. C.N. Chen, Y.S. Li, Y.T. Yeh, P.L. Lee, S. Usami, S. Chien, and J.J. Chiu Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells Proc. Natl. Acad. Sci. U. S. A. 103 2006 2665 2670
9. C.Y. Cheng, C.T. Kuo, C.C. Lin, H.L. Hsieh, and C.M. Yang IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells Br. J. Pharmacol. 160 2010 1595 15610
10. D.D. Dahlen, N.L. Lin, Y.C. Liu, and V.C. Broudy Soluble Kit receptor blocks stem cell factor bioactivity in vitro Leuk. Res. 25 2001 413 421 (Pubitemid 32294287)
11. S. Drube, S. Heink, S. Walter, T. Lohn, M. Grusser, A. Gerbaulet, L. Berod, J. Schons, A. Dudeck, J. Freitag, S. Grotha, D. Reich, O. Rudeschko, J. Norgauer, K. Hartmann, A. Roers, and T. Kamradt The receptor tyrosine kinase c-Kit controls IL-33 receptor signalling in mast cells Blood 115 2010 3899 3906
12. L.H. Ho, T. Ohno, K. Oboki, N. Kajiwara, H. Suto, M. Iikura, Y. Okayama, S. Akira, H. Saito, S.J. Galli, and S. Nakae IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals J. Leukoc. Biol. 82 2007 1481 1490 (Pubitemid 350276960)
13. C.L. Hsu, C.V. Neilsen, and B.J. Bryce IL-33 is produced by mast cells and regulates IgE-dependent inflammation PLoS One 5 2010 e11944
14. M. Iikura, H. Suto, N. Kajiwara, K. Oboki, T. Ohno, Y. Okayama, H. Saito, S.J. Galli, and S. Nakae IL-33 can promote survival, adhesion and cytokine production in human mast cells Lab. Invest. 87 2007 971 978 (Pubitemid 47429189)
15. K. Kandere-Grzybowska, D. Kempuraj, J. Cao, C.L. Cetrulo, and T.C. Theoharides Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin Br. J. Pharmacol. 148 2006 208 215 (Pubitemid 43873039)
16. M.W. Karaman, S. Herrgard, D.K. Treiber, P. Gallant, C.E. Atteridge, B.T. Campbell, K.W. Chan, P. Ciceri, M.I. Davis, P.T. Edeen, R. Faraoni, M. Floyd, J.P. Hunt, D.J. Lockhart, Z.V. Milanov, M.J. Morrison, G. Pallares, H.K. Patel, S. Pritchard, L.M. Wodicka, and P.P. Zarrinkar A quantitative analysis of kinase inhibitor selectivity Nat. Biotechnol. 26 2008 127 132
17. G.Y. Kim, J.W. Lee, H.C. Ryu, J.D. Wei, C.M. Seong, and J.H. Kim Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis J. Immunol. 184 2010 3946 3954
18. J. Lennartsson, T. Jelacic, D. Linnekin, and R. Shivakrupa Normal and oncogenic forms of the receptor tyrosine kinase kit Stem Cells 23 2005 16 43 (Pubitemid 40105289)
19. M.L. Leonore, W.H. Tuyt, A. Dokter, K. Birkenkamp, S.B. Koopmans, C. Lummen, W. Kruijter, and E. Vellenga Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-κB-dependent IL-6 expression in human monocytes J. Immunol. 162 1999 4893 4902 (Pubitemid 29314894)
20. F.Y. Liew, N.I. Pitman, and I.B. McInnes Disease-associated functions of IL-33: the new kid in the IL-1 family Nat. Rev. Immunol. 10 2010 103 110
21. C.C. Lin, C.W. Lee, T.H. Chu, C.Y. Cheng, S.F. Luo, L.D. Hsiao, and C.M. Yang Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-induced ICAM-1 expression in A549 cells J. Cell. Physiol. 211 2007 771 780
22. J.L. Mitcham, P. Parnet, T.P. Bonnert, K.E. Garka, M.J. Gerhart, J.L. Slack, M.A. Gayle, S.K. Dower, and J.E. Sims T1/ST2 signalling establishes it as a member of an expanding interleukin-1 receptor family J. Biol. Chem. 271 1996 5777 5783 (Pubitemid 26083916)
23. M.F. Nold, C.A. Nold-Petry, J.A. Zepp, B.E. Palmer, P. Bufler, and C.A. Dinarello IL-37 is a fundamental inhibitor of innate immunity Nat. Immunol. 11 2010 1014 1022
24. T. Ohno, K. Obok, H. Morita, N. Kajiwara, K. Arae, S. Tanaka, M. Ikeda, M. Iikura, T. Akiyama, J. Inoue, K. Matsumoto, K. Sudo, M. Azuma, K. Okumura, T. Kamradt, H. Saito, and S. Nakae Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation PLoS One 6 2011 e18404
25. G. Palmer, B.P. Lipsky, M.D. Smithgall, D. Meininger, S. Siu, D. Talabot-Ayer, C. Gabay, and D.E. Smith The IL-1 receptor accessory protein (AcP) is required for IL-33 signalling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 Cytokine 42 2008 358 364
26. J. Pan, A. Quintas-Cardama, H.M. Kantarjian, C. Akin, T. Manshouri, P. Lamb, J.E. Cortes, A. Tefferi, F.J. Giles, and S. Verstovsek EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation Blood 109 2007 315 322 (Pubitemid 46053072)
27. X. Piao, R. Paulson, P. van der Geer, T. Pawson, and A. Bernstein Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1 Proc. Natl. Acad. Sci. U. S. A. 93 1996 14665 14669
28. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, and R.A. Kastelein IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490 (Pubitemid 41587888)
29. J. Sun, M. Pedersen, and L. Ronnstrand The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction J. Biol. Chem. 284 2009 11039 11047
30. S. Tanida, T. Joh, K. Itoh, H. Kataoka, M. Sasaki, H. Ohara, T. Nakazawa, T. Nomura, Y. Kinugasa, H. Ohmoto, H. Ishiguro, K. Yoshino, S. Higashiyama, and M. Itoh The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells Gastroenterology 127 2004 559 569 (Pubitemid 39091904)
31. H. Wesche, C. Korherr, M. Kracht, W. Falk, K. Resch, and M.U. Martin The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases) J. Biol. Chem. 272 1997 7727 7731 (Pubitemid 27137325)
32. R. Wetzker, and F.D. Bohmer Transactivation joins multiple tracks to the ERK/MAPK cascade Nat. Rev. Mol. Cell Biol. 4 2003 651 657 (Pubitemid 36934967)